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Abstract
Since the end of 2019 until present, coronavirus (CoV) disease (COVID)-2019 has spread globally and caused a 
pandemic. The disease is caused by severe acute respiratory syndrome-2 (SARS-CoV-2). The disease is showed 
to be less affecting pediatric population. The proportion children suffering from COVID-19 is only around 2% of total 
cases with only 0.08% mortality rate. Several hypotheses have been proposed regarding this condition. Children are 
supposed to be less exposed to patients with COVID-19, have lesser amount of angiotensin converting enzyme 2, 
have different immune response compared to adults, and have faster tissue recovery ability. All of them decrease the 
possibility of SARS-CoV-2 infection in pediatric population.
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Introduction
In December 2019, new cases of pneumonia 
were reported in China. The epicenter of the disease 
was suspected in Huanan seafood market in Wuhan, 
Hubei Province [1], [2], [3]. The disease was caused 
by severe acute respiratory syndrome-2 (SARS-
CoV-2) and was later named as coronavirus (CoV) 
disease-2019 (COVID-19) [4]. COVID-19 spread rapidly 
around the globe and was declared as a pandemic 
by World Health Organization in March 11, 2020 [5]. 
The most common mode of transmission is through 
respiratory droplet. There was no evidence regarding 
vertical transmission from mother to child [6], [7], [8]. 
However, antibody toward SARS-CoV-2 was detected 
in newborns from mothers with COVID-19. Therefore, 
separation of newborns from their COVID-19 infected 
mothers is advised [7].
The epidemiological data regarding COVID-19 
in children is not certain. It is due to lack of COVID-19 
screening in pediatric population from asymptomatic 
disease course in most of this population [7], [8]. 
Children are also less affected by COVID-19 compared 
to adults. The prevalence rates of pediatric COVID-19 
in China and Italy are 2% and 1.2%, respectively [7], [9]. 
Even more, neonatal case is very rare. Male children 
are affected more than female ones [7]. Most pediatric 
cases of COVID-19 are asymptomatic to mild with 
reported mortality of 0.08% [7], [8], [9]. Several 
hypotheses are raised regarding the low susceptibility 
and mortality of COVID-19 in children. We will discuss 
about the hypotheses in this review.
Pathogenesis of COVID-19
CoV is an enveloped single-stranded positive-
sense ribonucleic acid (RNA) virus. It consists of alpha 
and beta genera where SARS-CoV-2 belongs to beta 
genera [6], [10]. At first, COVID-19 is thought to be 
transmitted from snakes. Latterly, studies showed that 
mammals are the possible carriers for the disease [6]. 
After entering human’s body mainly through respiratory 
tract, virus’ spike glycoprotein (a surface glycoprotein) 
binds angiotensin converting enzyme (ACE) 2. This 
process is followed by fusion of virus with cell membrane. 
Virus’ RNA will integrate into host deoxyribonucleic 
acid. Host cell will then synthesize virus’ proteins. 
New viruses are assembled and ready to infect other 
cells, causing death in previous host cell [6], [11], [12]. 
The symptoms of COVID-19 are fever, cough, fatigue, 
dyspnea, and diarrhea. Some upper respiratory tract 
symptoms may present in COVID-19 patients such as 
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rhinorrhea, sneezing, and sore throat [6], [8], [9]. Real-
time polymerase chain reaction from nasopharyngeal 
swab is considered as the gold standard for diagnosing 
COVID-19 [6], [7].
“Lack of Exposure” Hypothesis
Human to human transmission occurs due 
to mutation of SARS-CoV-2 genome from its wild 
ancestor [13]. Compared to adults, children tend to 
have fewer outdoor activities. This gives this population 
a forced social and physical distancing even before 
the COVID-19 pandemic [14]. A study stated that the 
probability of children in contact with infected patients 
is 1.3% compared to 3.5% in adults [15]. This clearly 
lower the susceptibility of COVID-19 compared to adult 
population.
“Lack of Receptor” Hypothesis
Children have less mature and functional 
ACE2. As ACE2 is important viral receptor, this condition 
is suggested to be protective factor for COVID-19 in 
children [7], [9], [14]. This is supported by a fact that 
viral load in pediatric population is not different from that 
in adult ones. However, a study in rats showed that the 
quantity of ACE2 is decreased in older rats compared 
to younger ones [7].
“Different Immune Response” Hypothesis
Children have more active innate immune 
system which allows a more rapid clearance of the 
virus [14], [15], healthier respiratory tract due to less 
exposure of cigarette smoke and air pollutant, and less 
comorbidity [14]. Innate immune system consists of 
neutrophils, monocytes, macrophages, and dendritic 
cells. In newborns, both innate and adaptive immune 
system functions are not perfect. As time goes by, innate 
immune system getting more active before decreasing 
into adult state while adaptive immune system 
gradually active. As age advances, the immune system 
becomes impaired due to remodeling and declining 
processes [16]. The amount of antigen presenting cells 
in respiratory tract of children is similar with those in 
adults. In contrast, the amount of macrophages and 
monocytes is higher in children [17]. The presence of 
thymus in children causes an increase in lymphocyte 
maturation and number. Even though the lymphocyte 
function is impaired, its amount may improve host 
immunity toward viral infections [16].
Innate immune system eliminates viruses 
through production of interferons by dendritic cells and 
monocytes [15]. Those cells recognize viral nucleic 
acids through toll-like receptors. Interferons will activate 
natural killer cells and adaptive immune response to 
further helping in viral elimination. Natural killer cells 
lyse virus-infected cells and prevent viral replication 
and spreading [16], [18]. Innate immune system 
combined with T and B cell responses are important for 
viral clearance [15].
In the other hand, recurrent infection of the 
upper respiratory tract in children is postulated to 
induce a condition called trained immunity [15]. The 
concept of trained immunity was introduced in 2011. 
According to the concept, bacterial infection induces 
cross-protection against other pathogens [9]. In this 
condition, monocytes and other myeloid cells undergo 
epigenetic changes which increase their capability to 
eliminate antigens including SARS-CoV-2 [15].
Less comorbidity in children prevents immune 
over reactivity and further cytokine storm [15]. Adaptive 
immune system in children is also not well-developed, 
giving less cytokine production, and lower probability 
of cytokine storm [17]. That’s why children usually only 
show asymptomatic to mild COVID-19 manifestations. 
Similar reason underlies the low mortality rate of 
children with COVID-19 [15].
“Faster Recovery” Hypothesis
In children, tissue repair process is better 
compared to adults. Tissue repair is influenced by 
efferocytosis (non-inflammatory cell death) and M2 
repair program which is related with monocytes/
macrophages. These processes are mediated by 
resolvins. Resolvins are expressed more during 
childhood. However, infants aged <1 year are at higher 
risk of COVID-19. It is hypothesized that this population 
has immature immune response and absence trained 
immunity [15].
Conclusion
Several hypotheses have been proposed 
regarding the low susceptibility of COVID-19 in pediatric 
population. Children are less exposed to patients with 
COVID-19. They also have lower expression of ACE2 
and the SARS-CoV-2 receptor. Immune response in 
pediatric population is also different from adult, giving 
 Ruslie et al. Pediatric COVID-19
Open Access Maced J Med Sci. 2020 Sep 20; 8(T1):363-365. 365
protective effect toward COVID-19. Lastly, pediatric 
population possesses an ability of faster tissue recovery.
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